(Q47419390)

16 January 2018

title

Predictors of alternative medicine use by multiple sclerosis patients (English)

1 reference

16 January 2018

0 references

1

1 reference

16 January 2018

Olympia Hadjimichael

series ordinal

2

object named as

Olympia Hadjimichael

1 reference

16 January 2018

author name string

Timothy Vollmer

series ordinal

3

1 reference

16 January 2018

publication date

1 October 2003

1 reference

16 January 2018

Multiple Sclerosis Journal

published in

1 reference

16 January 2018

volume

9

1 reference

16 January 2018

issue

5

1 reference

16 January 2018

page(s)

461-466

1 reference

16 January 2018

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Why patients use alternative medicine: results of a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Are physicians aware of the risks of alternative medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Complementary and alternative therapies for treating multiple sclerosis symptoms: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Nonprescription medicine use in a multiple sclerosis clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Lead poisoning from complementary and alternative medicine in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Use of alternative health therapies by people with multiple sclerosis: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Demographic and health-related correlates to visits to complementary and alternative medical providers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

When can odds ratios mislead?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Use of Unproven Therapies by People with Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Alternative therapy use in neurologic diseases: use in brain tumor patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Prevalence and cost of alternative medicine in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Alternative therapies used by women with breast cancer in four ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS953OA

10.1191/1352458503MS953OA

21 January 2018

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018